Skip to main content
Premium Trial:

Request an Annual Quote

Australia to Award A$25M for Genomics Research into Diseases

NEW YORK (GenomeWeb) – The Australian government said today that it plans to award A$25 million (US$19.1 million) to one research team to conduct genomics research to prevent, diagnose, and treat diseases. 

The program, called Targeted Call for Research into Preparing Australia for the Genomics Revolution in Health Care, was announced today by the National Health and Medical Research Council. Under the program, a research team will receive the five-year award for a project that is expected to elucidate the impact of genomic data on patient care and to identify the economic and policy impacts of incorporating such data into the health system. The research resulting from the award is anticipated to help clinicians use genomics to manage diseases, such as cancer and diabetes, NHMRC said. 

"In health care today, we can already see how genomics is making a difference in the diagnosis of some diseases, including certain types of cancers," NHMRC CEO Warwick Anderson said in a statement. "The research conducted through this targeted call for research will yield new knowledge that will help us to understand how best to use the power of genomics to improve patient treatment."

The Scan

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.